Richard Vosser

Analyst-Equity en JPMorgan Securities Plc .

Finance

Perfil

Richard Vosser is currently the Head of Pharmaceuticals & Biotechnology at JPMorgan Securities Plc.
Previously, he worked as a Research Analyst at Bear Stearns International Ltd.

Cargos activos de Richard Vosser

Empresas	Cargo	Inicio
JPMorgan Securities Plc JPMorgan Securities Plc Financial ConglomeratesFinance JPMorgan Securities Plc is a brokerage firm headquartered in London, UK. The firm was founded in 1992 and is a wholly-owned subsidiary of JP Morgan Capital Holdings Ltd., ultimately owned by JPMorgan Chase & Co. (NYSE: JPM) in the US. JPMorgan Securities provides market research, proprietary pricing data and analytics, and trade execution across multiple asset classes such as credit, equities and FX. They help institutional investors, traditional and alternative asset and fund managers, broker dealers and equity issuers meet the demands of changing markets.	Analyst-Equity	01/06/2008

Todos los cargos activos de Richard Vosser

Antiguos cargos conocidos de Richard Vosser.

Empresas	Cargo	Fin
Bear Stearns International Ltd.	Analyst-Equity	-

Ver el detalle de la experiencia de Richard Vosser.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Richard Vosser.

Relaciones

100 +

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	2
Bear Stearns International Ltd.	Finance
JPMorgan Securities Plc JPMorgan Securities Plc Financial ConglomeratesFinance JPMorgan Securities Plc is a brokerage firm headquartered in London, UK. The firm was founded in 1992 and is a wholly-owned subsidiary of JP Morgan Capital Holdings Ltd., ultimately owned by JPMorgan Chase & Co. (NYSE: JPM) in the US. JPMorgan Securities provides market research, proprietary pricing data and analytics, and trade execution across multiple asset classes such as credit, equities and FX. They help institutional investors, traditional and alternative asset and fund managers, broker dealers and equity issuers meet the demands of changing markets.	Finance